CHC

  • About Us
  • News
  • Coming Up
  • Resources
  • Contact Us
  • Search

FDA Launches Bad Ad Program

May 12, 2010

Read about it then comment here on our site.

The FDA launched a new program Tuesday to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful and not misleading. And the agency gave the outreach canadian phamacy effort an apt name: The Bad Ad Program.

online jobs from home

Reuters news coveragecialis soft india

Posted in Regulatory/FDA

Post navigation

How Pharmaceutical Company Payments Can Be Beneficial to Physicians
ACRE Recommends Rejecting CEJA Report and Recommendations, Re: CME

Categories

  • CHC News
  • Courts/First Amendment
  • Data Privacy
  • Drug Pricing
  • DTC Advertising
  • General
  • Legislative
  • Off-label Promotion
  • Point of Care
  • Regulatory/FDA
  • Uncategorized
  • Washington Focus

Recent Posts

  • FTC Releases New Staff Paper on Harms to Kids & Teens from Online “Blurred” or Stealth Advertising
  • California AG Investigates Large Employers for CCPA Employee Data Compliance
  • FTC Issues Proposed Rule Identifying 7 Deceptive Marketing Review and Testimonial Practices
  • California Court Issues Order to Delay Enforcement of CPRA Regulations until March 2024
  • FTC Releases First Update to Endorsement Ad Guidelines in a Decade

Tags

4A's ACA ad tax Advertising Coalition CDER chc CMS coalition for healthcare communication conflict of interest Congress COVID-19 data privacy DDMAC drug prices in DTC ads drug pricing DTC DTC advertising DTC advertising FDA FDA Commissioner FDA Draft Guidance FDA enforcement FDA social media free speech gifts to physicians HHS John Kamp Jon Bigelow kamp Kate Rawson legislation litigation off-label off-label communication OPDP OPDP enforcement PhRMA regulation rx data Scott Gottlieb social media sunshine act Untitled Letter Warning Letter Wayne Pines
CHC

Smart Brief
© 2023 Coalition for Healthcare Communication. All rights reserved.